Application of Bronchoscopic TransParenchymal Nodule Access in tuberculous bronchial occlusion

Bronchoscopic TransParenchymal Nodule Access (BTPNA) technology is mainly used for sampling or ablative treatment of lung parenchymal lesions that cannot be reached by bronchoscopy and its appendages, generally for palliative treatment of some lung tumors. We used BTPNA to treat a 32‐year‐old young...

Full description

Saved in:
Bibliographic Details
Published inThe clinical respiratory journal Vol. 16; no. 12; pp. 842 - 848
Main Authors Jing, Qiusheng, Hu, Zhimin, Wu, Mingdi, Liu, Min, Yu, Panli, Sun, Ling, Chen, Xianxiang
Format Journal Article
LanguageEnglish
Published Copenhagen John Wiley & Sons, Inc 01.12.2022
John Wiley and Sons Inc
Wiley
Subjects
Brief Report
Bronchoscopy
bronchus
BTPNA
Case reports
occlusion
Tuberculosis
Online AccessGet full text

Cover

More Information
Summary:Bronchoscopic TransParenchymal Nodule Access (BTPNA) technology is mainly used for sampling or ablative treatment of lung parenchymal lesions that cannot be reached by bronchoscopy and its appendages, generally for palliative treatment of some lung tumors. We used BTPNA to treat a 32‐year‐old young woman with pulmonary tuberculosis and successfully perforated her occluded left main bronchus. Her left atelectasis was recovered, and a silicone stent was inserted to preserve the shape of the left main bronchus. BTPNA can be used to obtain lung nodules, and interventional vapour or radiofrequency ablation can be used to treat solitary lung tumor. Tunnelling technology can also be used to treat bronchial occlusion and open the airway.
Bibliography:Qiusheng Jing and Zhimin Hu are co‐first author.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1752-6981
1752-699X
DOI:10.1111/crj.13544